Skip to content
canadabiogenix-logo-only-clear-background-landscape
  • Shop Peptides
  • Cancer & Immune Research
  • Supplies
  • Our Story
  • Tools
    • Peptide FAQ
    • Dosage Calculator
    • Peptide Cheat Sheet
  • Blog
  • Shop Peptides
  • Cancer & Immune Research
  • Supplies
  • Our Story
  • Tools
    • Peptide FAQ
    • Dosage Calculator
    • Peptide Cheat Sheet
  • Blog
$0.00 0 Cart

Author: Canada Biogenix

Semax Mechanism of Action: How It Affects the Brain

Explore the semax mechanism of action, from neurotrophic effects to peptide reconstitution best practices and dosage protocols. Learn how it works.

Selank Mechanism of Action: How It Works

Explore Selank mechanism of action, from GABAergic transmission to BDNF expression. Learn how this synthetic peptide affects neurotransmitter modulation.

Epitalon Mechanism of Action: Research Guide

Explore Epitalon mechanism of action, from telomerase activation to pineal gland effects, plus peptide research safety standards and reconstitution tips.

Tesamorelin Mechanism of Action: GHRH Analogue Guide

Tesamorelin mechanism of action explained: how this GHRH analogue binds pituitary receptors, drives pulsatile GH release, and reduces visceral fat. Learn.

Ipamorelin Mechanism of Action: How It Works in 2026

Explore the ipamorelin mechanism: how this selective agonist binds GHS-R1a to drive pulsatile GH release, plus half-life, dosage and GHRP-6 comparison.

CJC-1295 Mechanism of Action: How It Works

Explore the CJC-1295 mechanism of action, from GHRH receptor binding to IGF-1 effects. Learn how this research peptide works in lab studies.

GLP-1 GIP Glucagon Mechanism: How It Works

Explore the GLP-1 GIP glucagon mechanism, from receptor signaling to metabolic research. Learn how these pathways work in 2026.

AMPK and Metabolism: How AMPK Activation Works

AMPK and metabolism explained: how AMPK activation mechanisms control energy balance, glucose, and fat burning. Learn what the research shows.

SLU-PP-332 Mechanism of Action: ERR Agonist Guide

Explore the SLU-PP-332 mechanism of action, ERR agonist activity, metabolic effects, and key research findings for Canadian peptide researchers.

Long Term Safety of Therapeutic Peptide Use: 2026 Guide

Explore the long term safety of therapeutic peptide use in 2026. Learn about purity standards, monitoring protocols, and regulatory oversight. Get.

← Previous
Next →
Facebook Instagram X-twitter

THESE MATERIALS ARE NOT APPROVED BY HEALTH CANADA FOR COSMETIC APPLICATION ON CLIENTS, THERAPEUTIC TREATMENT, INJECTION, INGESTION, OR ANY FORM OF HUMAN OR ANIMAL USE.

  • sales@canadabiogenix.com

Links

  • Privacy policy
  • Refund and Return Policy
  • Shipping Policy
  • Terms and Conditions
  • Privacy policy
  • Refund and Return Policy
  • Shipping Policy
  • Terms and Conditions

STAY CONNECTED

  • © 2026. All rights reserved.